Product Information
TRI-LO-SPRINTEC TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1049 per EA under NDC 00093214062. Its NADAC has been published 536 times since Mar 23, 2016.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093214062
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA076784On Market Since
12/30/2015
Price Statistics
The NADAC for TRI-LO-SPRINTEC TABLET has been published 536 times since Mar 23, 2016, and over the history we have for it it has declined 91.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1049 per EA |
|---|---|
| All-time high | $1.1840 (Apr 13, 2016) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1049 |
| Median price | $0.1726 |
| Average price | $0.2471 |
| Largest weekly change | -60.5% (Jan 18, 2017) |
| Weeks tracked | 536 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRI-LO-SPRINTEC TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-SPRINTEC TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1049 per EA (NDC 00093214062), effective Jun 24, 2026.
How has the price of TRI-LO-SPRINTEC TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-SPRINTEC TABLET has declined 91.1%. It has been tracked across 536 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for TRI-LO-SPRINTEC TABLET?
Since Mar 23, 2016, the NADAC for TRI-LO-SPRINTEC TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $1.1840 (Apr 13, 2016), with a median of $0.1726 per EA.
Are there cheaper alternatives to TRI-LO-SPRINTEC TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as TRI-LO-SPRINTEC TABLET, but none are currently priced below it.
Who manufactures TRI-LO-SPRINTEC TABLET?
TRI-LO-SPRINTEC TABLET (NDC 00093214062) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification